Skip to main content
BOFIK
    • Gene Editing
    • Epigenetic Reprogramming
    • Senolytics
    • Mitochondria & Metabolism
    • Regenerative Medicine
    • Drug Delivery
    • AI & Computational Biology
    • Clinical Trials
    • Biotech Business
    • Longevity Lifestyle
  • Latest
  • About
Subscribe
Menu
  • Home
  • Latest
  • Topics
  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery
  • AI & Computational Biology
  • Clinical Trials
  • Biotech Business
  • Longevity Lifestyle
  • About
Home / Latest / 2019 / January

January 2019

1 articles

January 21, 2019
Dasatinib + Quercetin Combination Shows Benefits in Human Pilot Study
Senolytics

Dasatinib + Quercetin Combination Shows Benefits in Human Pilot Study

The first rigorous human trial of the popular senolytic combination demonstrates measurable improvements in physical function and frailty markers.

Dr. Sarah Chen Dr. Sarah Chen 6 min read

Archive

  • 2026
    • January 7
  • 2024
    • September 1
    • May 1
    • March 1
  • 2023
    • December 1
    • November 1
    • October 1
    • September 1
    • August 1
    • July 1
    • June 1
    • April 1
    • March 1
    • January 1
  • 2022
    • June 1
    • April 1
    • February 1
    • January 2
  • 2019
    • January 1
  • 2018
    • July 1

Newsletter

Get the latest bioengineering news in your inbox.

Stay Ahead of the Curve

Get the latest bioengineering and longevity news delivered to your inbox. No spam, unsubscribe anytime.

BOFIK

The Future of Human Longevity

Topics

  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery

Company

  • About Us
  • Editorial Team
  • Contact
  • RSS Feed

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy

© 2026 BOFIK. All rights reserved.